课题基金 / 基金详情

Diacylglycerol Kinase Delta in Growth and Development

Diacylglycerol Kinase Delta in Growth and Development
二酰甘油激酶 Delta 在生长和发育中的作用
批准号:
6623394
负责人:
MATTHEW KENT TOPHAM
金额:
$26.63万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2002
资助国家:
美国
项目状态:
已结题
起止时间:
2002-04-25 至 2007-03-31

项目摘要

项目成果

MATTHEW KENT TOPHAM的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Diacylglycerol kinases (DGKs) phosphorylate diacylglycerol (DAG) to generate phosphatidic acid (PA). Both DAG and PA have signaling properties, placing DGKs at an important biological crossroads. Nine mammalian DGKs have been identified, suggesting not only they are biologically important, but also that each of them has a distinct function. Because cells often express several DGK inhibitors- which can inhibit only three DGKs- it has been very difficult to determine the function of each DGK isozyme. Previous efforts to determine their functions have relied on overexpressing a DGKisotype or an inactive mutant. This is a simple and often effective approach, but has drawbacks because overexpressing a protein in cells can lead to non-specific effects. If proper controls are not included, the results can be misleading. An effective approach to circumvent these technical difficulties, is to engineer mice with targeted deletion of the gene of interest. So, to understand the role of each DGK isotype, we have initiated projects to delete the genes in mice. We found that mice with targeted deletion of DGKdelta, have a phenotype very similar to mice with targeted deletion of either the epidermal growth factor receptor (EGFR) or tumor necrosis factor-alpha converting enzyme (TACE). This similarity was surprising because there is no previous evidence indicating a role for DGKdelta or other DGKs in EGFR signaling. We have also observed that mice with targeted deletion of either DGKepsilon or iota do not have this phenotype, indicating that this is a distinct property of DGKdelta. Further studies indicated that deleting DGKdelta did not affect signaling events downstream of the EGFR, but instead suggested that DGK was necessary for proper activation of TACE, a transmembrane enzyme that proteolytically releases EGFR ligands from the cell surface. Indeed, DGKdelta co-immunoprecited with TACE and their association was enhanced in conditions known to activate TACE. Thus, it appears that a crucial event in TACE activation is its association with DGKdelta. However, the specific mechanism by which DGKdelta activates TACE is not clear. We hypothesize that DGKdelta associates either directly or indirectly with TACE and then activates growth factor shedding through its DAG kinase activity. Additionally, we believe that abnormal activity of DGKdelta will result in deregulated growth and development. In this proposal, we outline experiments to test hypotheses by dissecting the events leading to DGKdelta's activation of TACE and by examining the consequences of abnormally high DGKdelta activity.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Modulation of EGFR signaling by lipid mediators in colon carcinogenesis
  • 批准号:
    8449515
  • 项目类别:
  • 资助金额:
    $29.43万
  • 财政年份:
    2013
  • 负责人:
    MATTHEW KENT TOPHAM
  • 依托单位:
Modulation of EGFR signaling by lipid mediators in colon carcinogenesis
  • 批准号:
    8234101
  • 项目类别:
  • 资助金额:
    $31.57万
  • 财政年份:
    2011
  • 负责人:
    MATTHEW KENT TOPHAM
  • 依托单位:
Modulation of EGFR signaling by lipid mediators in colon carcinogenesis
  • 批准号:
    7786718
  • 项目类别:
  • 资助金额:
    $23.14万
  • 财政年份:
    2010
  • 负责人:
    MATTHEW KENT TOPHAM
  • 依托单位:
Diacylglycerol Kinase Delta in Growth and Development
  • 批准号:
    8109244
  • 项目类别:
  • 资助金额:
    $26.14万
  • 财政年份:
    2002
  • 负责人:
    MATTHEW KENT TOPHAM
  • 依托单位:
海外基金